» Articles » PMID: 28150718

Distinct Requirement of Runx Complexes for TCRβ Enhancer Activation at Distinct Developmental Stages

Overview
Journal Sci Rep
Specialty Science
Date 2017 Feb 3
PMID 28150718
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

A TCRβ enhancer, known as the Eβ enhancer, plays a critical role in V(D)J recombination and transcription of the Tcrb gene. However, the coordinated action of trans-acting factors in the activation of Eβ during T cell development remains uncharacterized. Here, we characterized the roles of Runx complexes in the regulation of the Eβ function. A single mutation at one of the two Runx binding motifs within the Eβ severely impaired Tcrb activation at the initiation phase in immature thymocytes. However, TCRβ expression level in mature thymocytes that developed under such a single Runx site mutation was similar to that of the control. In contrast, mutations at two Runx motifs eliminated Eβ activity, demonstrating that Runx complex binding is essential to initiate Eβ activation. In cells expressing Tcrb harboring rearranged V(D)J structure, Runx complexes are dispensable to maintain TCRβ expression, whereas Eβ itself is continuously required for TCRβ expression. These findings imply that Runx complexes are essential for Eβ activation at the initiation phase, but are not necessary for maintaining Eβ activity at later developmental stages. Collectively, our results indicate that the requirements of trans-acting factor for Eβ activity are differentially regulated, depending on the developmental stage and cellular activation status.

Citing Articles

Cell-type specific, inducible and acute degradation of targeted protein in mice by two degron systems.

Yamashita M, Ogawa C, Zhang B, Kobayashi T, Nomura A, Barker C Nat Commun. 2024; 15(1):10129.

PMID: 39613744 PMC: 11607430. DOI: 10.1038/s41467-024-54308-9.


Enhancers in T Cell development and malignant lesions.

Zhang T, Zou L Cell Death Discov. 2024; 10(1):406.

PMID: 39284807 PMC: 11405840. DOI: 10.1038/s41420-024-02160-7.


LAG-3 and PD-1 synergize on CD8 T cells to drive T cell exhaustion and hinder autocrine IFN-γ-dependent anti-tumor immunity.

Andrews L, Butler S, Cui J, Cillo A, Cardello C, Liu C Cell. 2024; 187(16):4355-4372.e22.

PMID: 39121848 PMC: 11323044. DOI: 10.1016/j.cell.2024.07.016.


Cutting Edge: LAG3 Dimerization Is Required for TCR/CD3 Interaction and Inhibition of Antitumor Immunity.

Adam K, Lipatova Z, Abdul Ghafoor Raja M, Mishra A, Mariuzza R, Workman C J Immunol. 2024; 213(1):7-13.

PMID: 38775415 PMC: 11182711. DOI: 10.4049/jimmunol.2300673.


The RUNX Family, a Novel Multifaceted Guardian of the Genome.

Dutta B, Osato M Cells. 2023; 12(2).

PMID: 36672189 PMC: 9856552. DOI: 10.3390/cells12020255.


References
1.
Yu M, Wan M, Zhang J, Wu J, Khatri R, Chi T . Nucleoprotein structure of the CD4 locus: implications for the mechanisms underlying CD4 regulation during T cell development. Proc Natl Acad Sci U S A. 2008; 105(10):3873-8. PMC: 2268827. DOI: 10.1073/pnas.0800810105. View

2.
Zhao K, Wang W, Rando O, Xue Y, Swiderek K, Kuo A . Rapid and phosphoinositol-dependent binding of the SWI/SNF-like BAF complex to chromatin after T lymphocyte receptor signaling. Cell. 1998; 95(5):625-36. DOI: 10.1016/s0092-8674(00)81633-5. View

3.
Leduc I, Hempel W, Mathieu N, Verthuy C, Bouvier G, Watrin F . T cell development in TCR beta enhancer-deleted mice: implications for alpha beta T cell lineage commitment and differentiation. J Immunol. 2000; 165(3):1364-73. DOI: 10.4049/jimmunol.165.3.1364. View

4.
Ellmeier W, Sunshine M, Losos K, Hatam F, Littman D . An enhancer that directs lineage-specific expression of CD8 in positively selected thymocytes and mature T cells. Immunity. 1997; 7(4):537-47. DOI: 10.1016/s1074-7613(00)80375-1. View

5.
Hernandez-Munain C, Krangel M . Distinct roles for c-Myb and core binding factor/polyoma enhancer-binding protein 2 in the assembly and function of a multiprotein complex on the TCR delta enhancer in vivo. J Immunol. 2002; 169(8):4362-9. DOI: 10.4049/jimmunol.169.8.4362. View